![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 13, 2020 1:44:29 PM
I ask the question once again: Does anyone have proof or hold that the platform that they have for glucose testing is inaccurate or invalid?
They have laid out in diagrams within their press releases what their tests are hoping to achieve and why it would work. The science is not from Berman. Berman laid out the prerequisites of how any test for COVID-19 based on the white papers would have to be designed and work with their established and tested platform.
They believe they have a valid design. Those you quote I have no idea of who they are, but resorting to just bashing people doesn't prove anything to me.
I don't know if the design will work or not. They believe (are confident) their test kits will work based on other testing. We shall know relatively soon (within several weeks) whether or not this moves forward or hits a dead end. If it moves forward, it won't stay anywhere near this price. IMO
I'm not saying anyone should put their life savings into this company. I do believe this offers a high risk/reward scenario.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM